JRSH
Jerash Holdings (US), Inc.
JRSH has the edge over NKE overall, supported by stronger fundamentals and stronger modeled upside.
NKE
NIKE, Inc.
NKE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
JRSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
JRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $4.11 | -44% |
| Fair | 14x | $6.75 | -8.1% |
| Current | 15x | $7.35 | — |
| Forward | 15x | $7.35 | — |
| Expensive | 26x | $12.70 | +73% |
Historical ranges are pointers, not guarantees.
JRSH's PE is in its fair range at 15.0x. On analysts' estimates for next year's earnings, today's price would be 15.2x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over JRSH in the historical PE scenario, which offers more potential upside but is not a forecast.
JRSH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
JRSH has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
JRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.49 | -1% |
| Q3 2026 | $0.49 | +717% |
| Q2 2026 | $0.37 | +429% |
| Q1 2026 | $0.27 | +$0.34 |
| Q4 2025 | $0.15 | +$0.46 |
| Q3 2025 | $0.06 | +$0.35 |
| Q2 2025 | $0.07 | +$0.38 |
| Q1 2025 | -$0.07 | +$0.09 |
| Q4 2024 | -$0.31 | -$0.24 |
JRSH has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
JRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.3M | +20% |
| Q2 2026 | $50.2M | +27% |
| Q1 2026 | $42.9M | +47% |
| Q4 2025 | $41.8M | +18% |
| Q3 2025 | $42M | +4.3% |
| Q2 2025 | $39.6M | -3.2% |
| Q1 2025 | $29.3M | +36% |
| Q4 2024 | $35.4M | +29% |
JRSH has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +3.5 points |
| Q2 2026 | 5.2% | +2.8 points |
| Q1 2026 | 5.5% | +4 points |
| Q4 2025 | 4.7% | +2.7 points |
| Q3 2025 | 2.6% | -0.2 points |
| Q2 2025 | 2.4% | +4.4 points |
| Q1 2025 | 1.5% | +16 points |
| Q4 2024 | 2% | +0.6 points |
JRSH's operating margin was 6.1% last quarter, up 3.5 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over JRSH on profitability, with a higher operating margin.
JRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4M | -32% |
| Q2 2026 | $2.3M | +$9.3M |
| Q1 2026 | $1.8M | +21% |
| Q4 2025 | -$3.9M | -$750.5K |
| Q3 2025 | $6.4M | +46% |
| Q2 2025 | -$6.9M | -$4.6M |
| Q1 2025 | $1.5M | +$7.3M |
| Q4 2024 | -$3.2M | -$2.7M |
JRSH has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
JRSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +113K shares |
| 1 year | +2.5% | +326K shares |
| 3 years | +9.8% | +1.2M shares |
| 5 years | +17% | +2M shares |
| Available history | +18% | +2.1M shares |
JRSH has 14M diluted shares, up 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | $397,152 |
| Q4 2022 | $224,181 |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over JRSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
JRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -4.6x | Net Cash |
| Q4 2024 | -13.3x | Net Cash |
JRSH has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
JRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 84.7 | Overbought |
| Stochastic | 74.8 | Neutral |
JRSH's weekly RSI is 85 (overbought) and its Stochastic is 75 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
JRSH PE vs Consumer Cyclical Sector
| Metric | JRSH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 58 | 47 | 11 pts above |
JRSH has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
JRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.21 | 18% above |
| 20 week MA | $5.50 | 34% above |
| 50 week MA | $4.16 | 77% above |
| 100 week MA | $3.75 | 96% above |
| 200 week MA | $3.60 | 104% above |
JRSH has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
JRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.02 | $5.52 | -8.3% |
| 2021 | $5.52 | $6.70 | +21% |
| 2022 | $6.70 | $4.03 | -40% |
| 2023 | $4.03 | $3.11 | -23% |
| 2024 | $3.11 | $3.43 | +10% |
| 2025 | $3.43 | $3.03 | -12% |
| 2026 YTD | $3.03 | $7.35 | +143% |
JRSH has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.